How to use the Harmonising Outcome Measures for Eczema Core Outcome Set for atopic dermatitis trials: a users’ guide
British Journal of Dermatology · 15.03.2024 · 190 (4) · 527-535
DOI: 10.1093/bjd/ljad497 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Dermatology, online erschienen am 20.12.2023. Verfasst von Kim S Thomas und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Evidence Based Dermatology, School of Medicine, University of Nottingham, Nottingham, UK. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Eczema. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The Harmonising Outcome Measures for Eczema (HOME) initiative has agreed upon the Core Outcome Set (COS) for use in atopic dermatitis (AD) clinical trials, but additional guidance is needed to maximize its uptake.
Objectives
To provide answers to some of the commonly asked questions about using the HOME COS; to provide data to help with the interpretation of trial results; and to support sample size calculations for future trials. Methods and results We provide practical guidance on the use of the HOME COS for investigators planning clinical trials in patients with AD. It answers some of the common questions about using the HOME COS, how to access the outcome measurement instruments, what training/resources are needed to use them appropriately and clarifies when the COS is applicable. We also provide exemplar data to inform sample size calculations for eczema trials and encourage standardized data collection and reporting of the COS.
Conclusions
By encouraging adoption of the COS and facilitating consistent reporting of outcome data, it is hoped that the results of eczema trials will be more comprehensive and readily combined in meta-analyses and that patient care will subsequently be improved.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Centre of Evidence Based Dermatology, School of Medicine, University of Nottingham, Nottingham, UK.
- Division of Dermatology, Rabin Medical Center, Petach-Tikva, Israel.
- School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
- Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.
- Institute of Social Medicine and Health Systems Research, Otto von Guericke University Magdeburg, Magdeburg, Germany.
- Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore.
ORCID-Profile: Kim S Thomas, Laura Howells, Yael A Leshem, Christian Apfelbacher, Michael E Jacobson
Zitieren
APA
Thomas, K. S., Howells, L., Leshem, Y. A., Simpson, E. L., Apfelbacher, C., Spuls, P. I., Gerbens, L. A. A., Jacobson, M. E., Katoh, N., Williams, H. C., & Stuart, B. L. (2024). How to use the Harmonising Outcome Measures for Eczema Core Outcome Set for atopic dermatitis trials: a users’ guide. British Journal of Dermatology, 190(4), 527-535. https://doi.org/10.1093/bjd/ljad497
Vancouver
Thomas KS, Howells L, Leshem YA, Simpson EL, Apfelbacher C, Spuls PI, et al. How to use the Harmonising Outcome Measures for Eczema Core Outcome Set for atopic dermatitis trials: a users’ guide. British Journal of Dermatology. 2024;190(4):527-535. doi:10.1093/bjd/ljad497
BibTeX
@article{Thomas2024,
author = {Thomas, Kim S and Howells, Laura and Leshem, Yael A and Simpson, Eric L and Apfelbacher, Christian and Spuls, Phyllis I and Gerbens, Louise A A and Jacobson, Michael E and Katoh, Norito and Williams, Hywel C and Stuart, Beth L},
title = {How to use the Harmonising Outcome Measures for Eczema Core Outcome Set for atopic dermatitis trials: a users’ guide},
journal = {British Journal of Dermatology},
year = {2024},
volume = {190},
number = {4},
pages = {527--535},
doi = {10.1093/bjd/ljad497}
}
EUVIMED